XML 47 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity - Additional Information (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 108 Months Ended
Jan. 27, 2020
USD ($)
$ / shares
shares
Jun. 24, 2019
USD ($)
$ / shares
shares
Jun. 07, 2018
Jul. 14, 2006
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2020
CAD ($)
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2028
Dec. 31, 2019
USD ($)
shares
Subsidiary or Equity Method Investee [Line Items]                      
Shares issue price (in dollars per share) | $ / shares $ 46.50 $ 18.00                  
Preferred stock, shares issued (in shares)         0   0       0
Preferred stock, shares outstanding (in shares)         0   0       0
Shares granted with respect to maximum fixed amount equal, percentage       20.00%              
Options granted under original plan exercisable period             10 years 10 years      
Options granted under the new plan exerciseable period       4 years              
Proceeds from stock options exercised             $ 1,795,000 $ 2,400      
Unamortized compensation expense related to unvested options             $ 34,550,000 $ 47,286      
Remaining unamortized compensation expense, weighted-average period             1 year 9 months 18 days 1 year 9 months 18 days      
Total amount contributed by ESPP participants | $         $ 701,000   $ 701,000       $ 435,000
Offering                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of shares issued (in shares) 5,824,729 7,013,892                  
Pre funded warrants issued in lieu of common shares to underwriters (in shares) 1,075,271 4,166,690                  
Warrants issued price (in dollars per share) | $ / shares $ 46.4999 $ 17.9999                  
Net proceeds from issuance | $ $ 300,900,000 $ 188,000,000.0                  
Underwriting discounts, commissions and offering expenses | $ $ 19,900,000 $ 13,300,000                  
Warrant exercise price (in dollars per share) | $ / shares $ 0.0001 $ 0.0001                  
Over-Allotment Option                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of shares issued to underwriters (in shares) 900,000 1,458,336                  
Restricted Share Units (RSUs)                      
Subsidiary or Equity Method Investee [Line Items]                      
Options granted under the new plan exerciseable period             3 years 3 years      
Grants in period (in shares)             78,679 78,679      
Grant date fair value | $             $ 2,786,000        
Compensation charge | $         $ 411,000 $ 0 $ 503,000   $ 0    
U.S Dollar Under the New Option Stock Plan                      
Subsidiary or Equity Method Investee [Line Items]                      
Shares granted with respect to maximum fixed amount equal, percentage     20.00%                
Options granted under the new plan exerciseable period             10 years 10 years      
Maximum number of common shares reserved for issuance (in shares)         8,654,682   8,654,682        
Shares issuable upon exercise of stock options (in shares)         6,294,820   6,294,820        
Employees Stock Purchase Plan                      
Subsidiary or Equity Method Investee [Line Items]                      
Share-based compensation arrangement by share-based payment award, plan modification, description and terms             On June 7, 2018, certain amendments to the ESPP were approved by shareholders. Prior to these amendments, the ESPP allowed eligible employees to acquire common shares at a discounted purchase price of 85% of the market value of the Company's common shares on the purchase date. The ESPP, as amended, allows eligible employees to acquire common shares at a discounted purchase price of the lesser of (i) 85% of the market price of a common share on the first day of the applicable purchase period and (ii) 85% of the market price of a common share on the purchase date. On June 7, 2018, certain amendments to the ESPP were approved by shareholders. Prior to these amendments, the ESPP allowed eligible employees to acquire common shares at a discounted purchase price of 85% of the market value of the Company's common shares on the purchase date. The ESPP, as amended, allows eligible employees to acquire common shares at a discounted purchase price of the lesser of (i) 85% of the market price of a common share on the first day of the applicable purchase period and (ii) 85% of the market price of a common share on the purchase date.      
Maximum eligible employees contribution under ESPP         15.00%   15.00%        
Purchase of shares under ESPP, maximum limit for each employee | $             $ 25,000        
Compensation charge | $             $ 311,000   $ 131,000    
Employees Stock Purchase Plan | Prior to Amendment                      
Subsidiary or Equity Method Investee [Line Items]                      
Percentage of discounted purchase price of average market price     85.00%                
Employees Stock Purchase Plan | After Amendment                      
Subsidiary or Equity Method Investee [Line Items]                      
Percentage of discounted purchase price of average market price     85.00%                
Director                      
Subsidiary or Equity Method Investee [Line Items]                      
Options granted under the new plan exerciseable period       3 years              
Forecast | U.S Dollar Under the New Option Stock Plan                      
Subsidiary or Equity Method Investee [Line Items]                      
Maximum number of common shares reserved for issuance increase in percentage                   4.00%